Edodekin alfa Completed Phase 2 Trials for Cervical Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00003017
Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix